Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  2018-01-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.abb.2017.12.009PMID 29233643PMCID PMC5762261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SIRT6 regulates Ras-related protein R-Ras2 by lysine defatty-acylation

  2017cited by this paper
• SIRT6: Novel Mechanisms and Links to Aging and Disease.

  2017cited by this paper
• A Review on SIRtuins in Diabetes.

  2017cited by this paper
• Reducing Smad3/ATF4 was essential for Sirt1 inhibiting ER stress-induced apoptosis in mice brown adipose tissue

  2016cited by this paper
• Regulation of SIRT1 in aging: Roles in mitochondrial function and biogenesis.

  2016cited by this paper
• Role of Sirt3 in mitochondrial biogenesis and developmental competence of human in vitro matured oocytes.

  2016cited by this paper
• SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein–Dependent Apoptotic Pathway

  2016cited by this paper
• Histone Deacetylase SIRT1 Controls Proliferation, Circadian Rhythm, and Lipid Metabolism during Liver Regeneration in Mice*

  2016cited by this paper
• E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells

  2015cited by this paper
• Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a

  2015cited by this paper
• Sirtuin 3 Mediates Neuroprotection of Ketones against Ischemic Stroke

  2015cited by this paper
• Lamin A Is an Endogenous SIRT6 Activator and Promotes SIRT6-Mediated DNA Repair.

  2015cited by this paper
• Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics.

  2015cited by this paper
• Putative tumor suppression function of SIRT6 in endometrial cancer

  2015cited by this paper
• Photoaffinity labeling in target- and binding-site identification.

  2015cited by this paper
• Discovery of novel and selective SIRT6 inhibitors.

  2014cited by this paper
• Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors.

  2014cited by this paper
• Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion

  2014cited by this paper
• p53 Acetylation: Regulation and Consequences

  2014cited by this paper
• Mechanism of Inhibition of the Human Sirtuin Enzyme SIRT3 by Nicotinamide: Computational and Experimental Studies

  2014cited by this paper
• A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests

  2013cited by this paper
• Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration

  2013cited by this paper
• Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins* ♦

  2013cited by this paper
• Sirt6 Regulates Tnf-Alpha Secretion Through Hydrolysis of Long-Chain Fatty Acyl Lysine

  2013cited by this paper
• Sirt6 regulates TNFα secretion via hydrolysis of long chain fatty acyl lysine

  2013cited by this paper
• Sirt5 Deacylation Activities Show Differential Sensitivities to Nicotinamide Inhibition

  2012cited by this paper
• Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells

  2012cited by this paper
• The sirtuin SIRT6 regulates lifespan in male mice

  2012cited by this paper
• The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.

  2012cited by this paper
• Transcription levels of sirtuin family in neural stem cells and brain tissues of adult mice.

  2012cited by this paper
• Inhibitors of Histone Deacetylases

  2011cited by this paper
• Structure and Biochemical Functions of SIRT6*

  2011cited by this paper
• SIRT6 Promotes DNA Repair Under Stress by Activating PARP1

  2011cited by this paper
• INHIBITORS OF HISTONE DEACETYLASES : CORRELATION BETWEEN ISOFORM SPECIFICITY AND REACTIVATION OF HIV-1 FROM LATENTLY INFECTED CELLS *

  2011cited by this paper
• Discovery, Biological Activity, Synthesis and Potential Therapeutic Utility of Naturally Occurring Histone Deacetylase Inhibitors

  2010cited by this paper
• Human SIRT6 Promotes DNA End Resection Through CtIP Deacetylation

  2010cited by this paper
• Mammalian sirtuins: biological insights and disease relevance.

  2010cited by this paper
• Functional dissection of SIRT6: identification of domains that regulate histone deacetylase activity and chromatin localization.

  2010cited by this paper
• Structural basis for sirtuin function: what we know and what we don't.

  2010cited by this paper
• SIRT6 Deficiency Results in Severe Hypoglycemia by Enhancing Both Basal and Insulin-stimulated Glucose Uptake in Mice*

  2010cited by this paper
• Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner

  2009cited by this paper
• Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.

  2009cited by this paper
• Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6

  2009cited by this paper
• Discovery, biological activity, synthesis and potential therapeutic utility of naturally occurring histone deacetylase inhibitors.

  2009cited by this paper
• Regulation of SIRT6 protein levels by nutrient availability

  2008cited by this paper
• SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

  2008cited by this paper
• Plasmodium falciparum Sir2 is an NAD+-dependent deacetylase and an acetyllysine-dependent and acetyllysine-independent NAD+ glycohydrolase.

  2008cited by this paper
• Is there a code embedded in proteins that is based on post-translational modifications?

  2008cited by this paper
• Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.

  2007cited by this paper
• Alkylating agent methyl methanesulfonate (MMS) induces a wave of global protein hyperacetylation: implications in cancer cell death.

  2007cited by this paper
• Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease

  2007cited by this paper
• Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

  2006cited by this paper
• The biochemistry of sirtuins.

  2006cited by this paper
• Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction*

  2006cited by this paper
• Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.

  2005cited by this paper
• Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.

  2004cited by this paper
• Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo.

  2004cited by this paper
• Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.

  2003cited by this paper
• Mechanism of Nicotinamide Inhibition and Transglycosidation by Sir2 Histone/Protein Deacetylases*

  2003cited by this paper
• Differential regulation of the Sir2 histone deacetylase gene family by inhibitors of class I and II histone deacetylases

  2003cited by this paper
• MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation

  2002cited by this paper
• Concurrent quantification of quinolinic, picolinic, and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry.

  2002cited by this paper
• Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1*

  2002cited by this paper
• Structural Identification of 2′- and 3′-O-Acetyl-ADP-ribose as Novel Metabolites Derived from the Sir2 Family of β-NAD+-dependent Histone/Protein Deacetylases* 210

  2002cited by this paper
• Conserved Enzymatic Production and Biological Effect of O-Acetyl-ADP-ribose by Silent Information Regulator 2-like NAD+-dependent Deacetylases*

  2002cited by this paper
• Acetylation of p53 Inhibits Its Ubiquitination by Mdm2*

  2002cited by this paper
• Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin.

  2001cited by this paper
• Negative Control of p53 by Sir2 Promotes Cell Survival under Stress

  2001cited by this paper
• Negative control of p53 by Sir2alpha promotes cell survival under stress.

  2001cited by this paper
• hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

  2001cited by this paper
• Identification of a Class of Small Molecule Inhibitors of the Sirtuin Family of NAD-dependent Deacetylases by Phenotypic Screening*

  2001cited by this paper
• Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions.

  2001cited by this paper
• Cloning and characterization of a novel human histone deacetylase, HDAC8.

  2000cited by this paper
• Deacetylation of p53 modulates its effect on cell growth and apoptosis

  2000cited by this paper
• [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A].

  1990cited by this paper
• Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

  1990cited by this paper
• Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors.

  1969cited by this paper

• Acetylation and deacetylation dynamics in stress response to cancer and infections.

  2025cites this paper
• Apelin‐12 Attenuates LPS‐Induced Cellular Senescence in Human Dental Pulp Cells via SIRT6‐Mediated Pathways: Implications for Gingivitis Management

  2025cites this paper
• The Influence of Sirtuin 6 on Chondrocyte Senescence in Osteoarthritis Under Aging: Focusing on Mitochondrial Dysfunction and Oxidative Stress

  2025cites this paper
• Design and synthesis of guanidino derivatives of benzoate esters as SIRT6 inhibitors.

  2025cites this paper
• Multifunctional roles of MicroRNAs in regulating cell death during cerebral ischemic injury.

  2025cites this paper
• NAD⁺ Replenishment Mitigates Cardiomyocyte Senescence and Corrects Heart Failure with Preserved Ejection Fraction in Aged Mice

  2025cites this paper
• Ameliorative effect of GLP1 agonist on vascular calcification in normoglycemic aged rat aorta via miR34a/SIRT6/NRF2/HO-1 signalling pathway.

  2025cites this paper
• The advances in acetylation modification in senescence and aging-related diseases

  2025cites this paper
• Idebenone Antagonizes P53-Mediated Neuronal Oxidative Stress Injury by Regulating CD38-SIRT3 Protein Level

  2024cites this paper
• Structure-Guided Discovery of Subtype Selective SIRT6 Inhibitors with a β-Carboline Skeleton for the Treatment of Breast Cancer.

  2024cites this paper
• Activation and inhibition of sirtuins: From bench to bedside

  2024cites this paper
• Current Trends in Sirtuin Activator and Inhibitor Development

  2024cites this paper
• Merging cultures and disciplines to create a drug discovery ecosystem at Virginia commonwealth university: Medicinal chemistry, structural biology, molecular and behavioral pharmacology and computational chemistry

  2023cites this paper
• Emerging role and therapeutic implications of p53 in intervertebral disc degeneration

  2023cites this paper
• Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis in vivo

  2023cites this paper
• Activation of SIRT6 Deacetylation by DNA Strand Breaks

  2023cites this paper
• Multifunctional activity-based chemical probes for sirtuins

  2023cites this paper
• Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis

  2023cites this paper
• The role of mammalian Sirtuin 6 in cardiovascular diseases and diabetes mellitus

  2023cites this paper
• Targeting epigenetic modifications in Parkinson's disease therapy

  2023cites this paper
• Sirtuin 6—A Key Regulator of Hepatic Lipid Metabolism and Liver Health

  2023cites this paper
• SIRT6 in Aging, Metabolism, Inflammation and Cardiovascular Diseases

  2022influential citation
• The roles of HMGB1‐produced DNA gaps in DNA protection and aging biomarker reversal

  2022cites this paper
• The Zinc-Dependent HDACs: Non-Histone Substrates and Catalytic Deacylation Beyond Deacetylation.

  2022cites this paper
• Sirtuin 6 Is a Critical Epigenetic Regulator of Cancer.

  2022cites this paper
• The sirtuin family in health and disease

  2022cites this paper
• High-throughput functional annotation of natural products by integrated activity profiling

  2022cites this paper
• Deacetylation of Transcription Factors in Carcinogenesis

  2021cites this paper
• Histone Deacetylase Inhibitors: Providing New Insights and Therapeutic Avenues for Unlocking Human Birth

  2021cites this paper
• Stress-induced visceral pain in female rats is associated with epigenetic remodeling in the central nucleus of the amygdala

  2021cites this paper
• Emerging Therapeutic Potential of SIRT6 Modulators

  2021cites this paper
• Substrate-Dependent Sensitivity of SIRT1 to Nicotinamide Inhibition

  2021cites this paper
• A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity

  2021cites this paper
• NADPH levels affect cellular epigenetic state by inhibiting HDAC3–Ncor complex

  2021cites this paper
• Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators

  2020influential citation
• Dux-Mediated Corrections of Aberrant H3K9ac during 2-Cell Genome Activation Optimize Efficiency of Somatic Cell Nuclear Transfer.

  2020cites this paper
• Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy

  2020influential citation
• Emerging roles of SIRT6 in human diseases and its modulators

  2020cites this paper
• Epi-drugs as triple-negative breast cancer treatment.

  2020cites this paper
• Sirt6 Deacetylase: A Potential Key Regulator in the Prevention of Obesity, Diabetes and Neurodegenerative Disease

  2020cites this paper
• SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation

  2020cites this paper
• Structural Basis for Activation of Human Sirtuin 6 by Fluvastatin.

  2020cites this paper
• SIRT6 protects retinal ganglion cells against hydrogen peroxide-induced apoptosis and oxidative stress by promoting Nrf2/ARE signaling via inhibition of Bach1.

  2019cites this paper
• High-Throughput Functional Annotation of Natural Products by Integrated Activity Profiling

  2019cites this paper
• Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle–dependent in mammalian cells, and its inhibition slows cell growth

  2019cites this paper
• SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy

  2019cites this paper
• Interweaving Tumor Heterogeneity into the Cancer Epigenetic/Metabolic Axis

  2019cites this paper
• Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives

  2019cites this paper
• p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesis

  2018cites this paper
• Structural Basis of Sirtuin 6 Inhibition by the Hydroxamate Trichostatin A: Implications for Protein Deacylase Drug Development.

  2018cites this paper
• A Review of the Recent Advances Made with SIRT6 and its Implications on Aging Related Processes, Major Human Diseases, and Possible Therapeutic Targets

  2018cites this paper